Navigation Links
Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
Date:1/6/2012

EAST BRUNSWICK, N.J., Jan. 6, 2012 /PRNewswire/ --Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that a product-specific billing code, or permanent J-code, for KRYSTEXXA® (pegloticase) became available on January 1, 2012. The new J-code, J2507, was assigned by the Centers for Medicare and Medicaid Services (CMS) and will help simplify the billing and reimbursement process for prescribers of KRYSTEXXA, the first and only U.S. Food and Drug Administration (FDA) approved treatment for refractory chronic gout (RCG).

"The availability of a permanent J-code for KRYSTEXXA is a significant step toward ensuring that healthcare providers and their patients with severe and debilitating gout, or RCG, have access to the first and only product for RCG," said John H. Johnson, Chief Executive Officer and President of Savient Pharmaceuticals.

Comprehensive support and financial assistance programs for KRYSTEXXA are available through KRYSTEXXA Connexxions. To access KRYSTEXXA Connexxions, call 1-877-633-9521 or visit www.KRYSTEXXAConnexxions.com.

ABOUT KRYSTEXXA® 
KRYSTEXXA® (pegloticase) is a PEGylated uric acid specific enzyme for administration by intravenous infusion for the treatment of refractory chronic gout (RCG) in adult patients. KRYSTEXXA became commercially available in the U.S. by prescription on December 1, 2010 and is the only U.S. Food and Drug Administration approved product specifically indicated for the treatment of RCG. KRYSTEXXA is not recommended for the treatment of asymptomatic hyperuricemia.

For more information about KRYSTEXXA, please visit: http://www.KRYSTEXXA.com.

IMPORTANT SAFETY INFORMATION ABOUT TREATMENT WITH KRYSTEXXA®
KRYSTEXXA is not in
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
2. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
3. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
4. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
5. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
6. Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
7. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
8. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
9. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
10. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
11. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Calif. and BRUSSELS ... AMGN ) and UCB (Euronext Brussels: UCB) today ... evaluating effect of RomosozUmab Compared with Teriparatide in ... fracture pReviously treated with bisphosphonatE therapy). The study ... significant difference in favor of romosozumab in the ...
(Date:9/1/2015)... Sept. 1, 2015 Emerus Holdings, a ... emergent, inpatient and diagnostic care in partnership with ... a definitive agreement to receive a strategic investment ... a leading health care investment firm. ... patient-centric acute episodic and ambulatory clinical services to ...
(Date:9/1/2015)... IRVINE, Calif. , Sept. 1, 2015  Edwards ... in the science of heart valves and hemodynamic monitoring, ... Fargo Healthcare Conference at the Hyatt Regency Boston in ... 9, 2015. Michael A. Mussallem , ... keynote lunch speaker followed by a company discussion with ...
Breaking Medicine Technology:Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3
... /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: ... emerging leader in the development, assembly, marketing and sale ... that the Company,s growing business earned a BBB+ Credit Rating ... "Zhongguancun Association") and was approved as a member of ...
... SHANGHAI, Feb. 28, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... China-based pharmaceutical and biotechnology research and development outsourcing company, ... results for the fourth quarter and full year ended ... host a conference call to discuss the results at ...
Cached Medicine Technology:Dehaier Medical Awarded Strong Credit Rating From Beijing Zhongguancun Enterprises Credit Promotion Association 2Dehaier Medical Awarded Strong Credit Rating From Beijing Zhongguancun Enterprises Credit Promotion Association 3ShangPharma to Report Fourth Quarter and Full Year 2011 Financial Results on March 13, 2012 2
(Date:9/1/2015)... ... September 01, 2015 , ... In an article ... practices across the country are switching from traditional dental impressions to digital impressions ... dentist Dr. Sam Saleh of Ora Dentistry Spa, his practice has been an ...
(Date:9/1/2015)... ... , ... Earth Brands, ( http://www.earthbrands.com ) a comfort-meets-fashion women’s ... buys an Earth Brand shoe will be given an opportunity to plant a ... a nonprofit dedicated to planting more trees. Earth Brands products represent contemporary designs ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... it Red for Lymphoma awareness initiative, the nation’s premier and most high-profile lymphoma ...
(Date:9/1/2015)... ... September 01, 2015 , ... From Aug. 17-21, Calvary ... teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at Kingsborough Community College ... adult counselors, some of whom work for Calvary, and two junior counselors who were ...
(Date:9/1/2015)... ... 01, 2015 , ... Georgia State University and its partners ... in stemming sexual assaults on their campuses. , The free, evidence-based survey was ... assault researchers and student affairs professionals responding to calls by the Obama Administration ...
Breaking Medicine News(10 mins):Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Georgia State, Partners Introduce Climate Survey to Aid in Preventing Campus Sexual Assaults 2
... Calif., July 1 AMDL, Inc. (Amex:,ADL), ... Tustin, California, with major operations in the ... intent (LOI) has been signed between,AMDL,s wholly-owned ... ZhiTong Pharmaceutical, Ltd. (SZP). SZP is a,privately-held ...
... of US healthcare consumers would be prepared to pay higher taxes to ... consumer attitudes to the recruitment of nurses from overseas. , ... Carlsbad, ... to a recent morefocus group healthcare survey are concerned about the on-going ...
... is out and the first day of summer is upon us, the ... by outsmarting the sun when spending time outdoors. Although the most prevalent ... preventable. The majority of the more than 1 million annual U.S. cases ... ...
... WASHINGTON As more adults age into the high-risk ... methods to identify where they may have problems in ... A new, carefully validated questionnaire called Everyday Cognition (ECog), ... adult well, can sensitively evaluate the performance of everyday ...
... less prone to violence when taking medication, but ... continue to pose a higher risk even with ... at Duke University Medical Center. , "This is ... the effectiveness of several commonly-prescribed medications for schizophrenia ...
... as 4th & 5th Graders ,Walked the Walk and Talked ... Campaign, - Campaign Addresses Future Health Risks in State Where More Than ... ... San Diego to Ventura counties have received grants of up to,$1,000.00 in recognition ...
Cached Medicine News:Health News:AMDL Signs Letter of Intent to Purchase China-Based Pharmaceutical Distribution Company 2Health News:AMDL Signs Letter of Intent to Purchase China-Based Pharmaceutical Distribution Company 3Health News:Education More Important Than Immigration to Solve Nursing Shortage, Research Shows 2Health News:Education More Important Than Immigration to Solve Nursing Shortage, Research Shows 3Health News:Texas Oncology Urges Texans to ‘Save Your Skin:' Outsmart the Sun and Prevent Skin Cancer 2Health News:Texas Oncology Urges Texans to ‘Save Your Skin:' Outsmart the Sun and Prevent Skin Cancer 3Health News:Texas Oncology Urges Texans to ‘Save Your Skin:' Outsmart the Sun and Prevent Skin Cancer 4Health News:New 'everyday cognition' scale tracks how older adults function in daily life 2Health News:New 'everyday cognition' scale tracks how older adults function in daily life 3Health News:Violence declines with medication use in some with schizophrenia 2Health News:So. Calif. Schools Receive $14,500 From KID HEALTHY -- Steps To Healthy Living Campaign! 2Health News:So. Calif. Schools Receive $14,500 From KID HEALTHY -- Steps To Healthy Living Campaign! 3
Reptilase-Time from Bothrops atrox...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Pefakit TAFI Calibrators and Controls...
Plasma Control Level 2 - 1 ml...
Medicine Products: